Direkt zum Inhalt
Merck

Targeted Protein Acetylation in Cells Using Heterobifunctional Molecules.

Journal of the American Chemical Society (2021-10-01)
Wesley W Wang, Li-Yun Chen, Jacob M Wozniak, Appaso M Jadhav, Hayden Anderson, Taylor E Malone, Christopher G Parker
ZUSAMMENFASSUNG

Protein acetylation is a central event in orchestrating diverse cellular processes. However, current strategies to investigate protein acetylation in cells are often nonspecific or lack temporal and magnitude control. Here, we developed an acetylation tagging system, AceTAG, to induce acetylation of targeted proteins. The AceTAG system utilizes bifunctional molecules to direct the lysine acetyltransferase p300/CBP to proteins fused with the small protein tag FKBP12F36V, resulting in their induced acetylation. Using AceTAG, we induced targeted acetylation of a diverse array of proteins in cells, specifically histone H3.3, the NF-κB subunit p65/RelA, and the tumor suppressor p53. We demonstrate that targeted acetylation with the AceTAG system is rapid, selective, reversible and can be controlled in a dose-dependent fashion. AceTAG represents a useful strategy to modulate protein acetylation and should enable the exploration of targeted acetylation in basic biological and therapeutic contexts.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Anti-Acetyl-c-Myc (Lys323)-Antikörper, from rabbit, purified by affinity chromatography